Charles Schwab Investment Management Inc Novartis Ag Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Novartis Ag stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 157,256 shares of NVS stock, worth $15.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

157,256

Previous 138,266 13.73%

Holding current value

$15.5 Million

Previous $14.7 Million 22.88%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$106.13 - $120.89 $2.02 Million - $2.3 Million	18,990 Added 13.73%	157,256 $18.1 Million
Q2 2024 Aug 12, 2024	BUY	$92.57 - $107.37 $1.63 Million - $1.9 Million	17,662 Added 14.64%	138,266 $14.7 Million
Q1 2024 May 08, 2024	SELL	$95.27 - $108.47 $2.46 Million - $2.8 Million	-25,805 Reduced 17.63%	120,604 $11.7 Million
Q4 2023 Feb 06, 2024	SELL	$92.27 - $101.54 $391 Million - $430 Million	-4,237,440 Reduced 96.66%	146,409 $14.8 Million
Q3 2023 Nov 08, 2023	SELL	$94.73 - $105.13 $2.71 Million - $3.01 Million	-28,592 Reduced 0.65%	4,383,849 $447 Million
Q2 2023 Aug 09, 2023	SELL	$92.52 - $104.91 $4.62 Million - $5.24 Million	-49,942 Reduced 1.12%	4,412,441 $445 Million
Q1 2023 May 11, 2023	SELL	$80.03 - $92.81 $8.51 Million - $9.87 Million	-106,331 Reduced 2.33%	4,462,383 $411 Million
Q4 2022 Feb 13, 2023	BUY	$75.55 - $92.52 $3.12 Million - $3.82 Million	41,253 Added 0.91%	4,568,714 $414 Million
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $6.21 Million - $7.26 Million	83,210 Added 1.87%	4,527,461 $344 Million
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $3.63 Million - $4.22 Million	45,038 Added 1.02%	4,444,251 $376 Million
Q1 2022 May 13, 2022	BUY	$80.11 - $90.62 $15.5 Million - $17.5 Million	193,519 Added 4.6%	4,399,213 $386 Million
Q4 2021 Feb 11, 2022	BUY	$79.7 - $88.13 $7.11 Million - $7.86 Million	89,226 Added 2.17%	4,205,694 $368 Million
Q3 2021 Nov 16, 2021	BUY	$81.78 - $95.14 $3.14 Million - $3.65 Million	38,337 Added 0.94%	4,116,468 $337 Million
Q2 2021 Aug 16, 2021	BUY	$85.24 - $94.15 $5.02 Million - $5.54 Million	58,840 Added 1.46%	4,078,131 $372 Million
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $45.4 Million - $53.6 Million	-544,058 Reduced 11.92%	4,019,291 $344 Million
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $18.2 Million - $22 Million	-232,491 Reduced 4.85%	4,563,349 $431 Million
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $21.4 Million - $23.7 Million	-260,053 Reduced 5.14%	4,795,840 $417 Million
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $14 Million - $15.7 Million	-172,708 Reduced 3.3%	5,055,893 $442 Million
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $306 Million - $428 Million	4,323,827 Added 477.89%	5,228,601 $431 Million
Q4 2019 Feb 07, 2020	BUY	$84.35 - $95.37 $12.1 Million - $13.6 Million	142,947 Added 18.76%	904,774 $85.7 Million
Q3 2019 Nov 08, 2019	BUY	$85.54 - $94.26 $7.59 Million - $8.37 Million	88,776 Added 13.19%	761,827 $66.2 Million
Q2 2019 Aug 09, 2019	BUY	$75.4 - $92.8 $14 Million - $17.2 Million	185,151 Added 37.95%	673,051 $61.5 Million
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $36.7 Million - $42 Million	487,900 New	487,900 $46.9 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Novartis Ag Transaction History